- Report
- May 2025
- 267 Pages
Global
From €4345EUR$4,950USD£3,760GBP
- Report
- January 2026
- 198 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 185 Pages
Global
From €3950EUR$4,500USD£3,418GBP
- Report
- March 2025
- 175 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- February 2026
- 220 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- August 2025
- 147 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- February 2026
- 421 Pages
Global
From €6141EUR$6,995USD£5,313GBP
- Report
- November 2025
- 150 Pages
Global
From €5223EUR$5,950USD£4,519GBP
- Report
- May 2025
- 100 Pages
Global
From €5223EUR$5,950USD£4,519GBP
- Report
- January 2026
- 180 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 180 Pages
Global
From €3950EUR$4,500USD£3,418GBP
- Report
- June 2025
- 182 Pages
Global
From €3950EUR$4,500USD£3,418GBP
- Report
- April 2025
- 175 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- March 2025
- 200 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- February 2026
- 282 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 174 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1756EUR$2,000USD£1,519GBP
- Report
- May 2025
- 114 Pages
Global
From €4170EUR$4,750USD£3,608GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,271USD£3,134GBP
- Report
- November 2025
- 250 Pages
Global
From €3507EUR$3,995USD£3,034GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more